Amesite Pivots to AI Healthcare, Faces Profitability Hurdles

TL;DR

**AMST is making a risky bet on AI in healthcare; their pivot is bold, but profitability is a huge question mark against established giants.**

AI Summary

Amesite Inc. (AMST) completed a strategic pivot in fiscal year 2025, shifting its focus from an education-centric model to AI-powered solutions for the healthcare sector, specifically targeting the post-acute care market. The company operates two product lines under its NurseMagic brand: a B2C app for individual nurses and caregivers, and a B2B enterprise platform for healthcare businesses like home health and skilled nursing facilities. The B2C app offers a free version to lower adoption barriers and gather feedback, while the B2B solution emphasizes workflow efficiency, data security, and regulatory compliance, including HIPAA. Amesite reported an aggregate market value of common stock held by non-affiliates of approximately $15,375,000 as of December 31, 2024, with a closing price of $4.75 per share. The company holds fourteen U.S. patents and has one pending U.S. patent application, alongside registered trademarks for AMESITE, KEEP LEARNING, LEARNING COMMUNITY ENVIRONMENT, and pending applications for PREACTO and NURSEMAGIC. Significant risks include the ability to generate sufficient revenue to become profitable, obtain additional funds, and navigate intense competition from established EMR/EHR firms and new AI-first entrants.

Why It Matters

Amesite's strategic pivot to AI-powered healthcare solutions, particularly NurseMagic, positions it in a high-growth, yet highly competitive, market. For investors, the company's ability to convert its free B2C user base into B2B enterprise contracts will be crucial for revenue growth and profitability, especially given the $15.375 million market value of non-affiliate common stock. Employees and customers in the post-acute care sector could benefit from improved efficiency and compliance tools, but the company must overcome established players like EMR/EHR firms. The broader market will watch if Amesite can carve out a sustainable niche in the crowded digital health space, demonstrating measurable ROI to drive adoption.

Risk Assessment

Risk Level: high — Amesite explicitly states risks including its 'ability to deliver our Site to our customers at a price point that enables us to generate sufficient revenue to become profitable' and 'our ability to continue as a going concern.' The company also highlights 'substantial competition from existing players' and the 'additional work of convincing customers to choose our technology-driven approach,' indicating significant market penetration challenges.

Analyst Insight

Investors should approach AMST with extreme caution, recognizing the high-risk, high-reward nature of its strategic pivot. Monitor B2B contract growth and revenue generation closely, as the free B2C model alone won't drive profitability. Await clearer signs of market traction and financial stability before considering a position.

Financial Highlights

debt To Equity

Not Disclosed

revenue

Not Disclosed

operating Margin

Not Disclosed

total Assets

Not Disclosed

total Debt

Not Disclosed

net Income

Not Disclosed

eps

Not Disclosed

gross Margin

Not Disclosed

cash Position

Not Disclosed

revenue Growth

Not Disclosed

Revenue Breakdown

Executive Compensation

Key Numbers

• $15,375,000 — Aggregate market value of common stock held by non-affiliates (as of December 31, 2024, indicating current market valuation)
• $4.75 — Closing price per share of common stock (on Nasdaq Capital Market on December 31, 2024)
• 4,572,713 — Shares of common stock outstanding (as of September 29, 2025)
• 14 — U.S. patents received (11 utility, 3 design, protecting core technology)
• 1 — Pending U.S. patent application (covering artificial intelligence platform)
• 5+ — New features and capabilities launched per week (demonstrates R&D agility and continuous improvement)

Key Players & Entities

• Amesite Inc. (company) — registrant
• AMST (company) — ticker symbol
• NurseMagic (company) — product brand
• Nasdaq Stock Market LLC (regulator) — exchange where common stock is registered
• U.S. Patent and Trademark Office (regulator) — intellectual property registration
• Health Insurance Portability and Accountability Act (regulator) — HIPAA compliance
• HITECH Act (regulator) — healthcare regulation
• Centers for Medicare & Medicaid Services (regulator) — CMS standards
• Federal Trade Commission (regulator) — consumer protection oversight
• U.S. Department of Health and Human Services (regulator) — HHS oversight

FAQ

Risk Factors

• Profitability and Funding [high — financial]: The company faces significant risks in generating sufficient revenue to achieve profitability and may require additional funding to sustain operations and growth. This is a critical concern given the pivot to a new market.
• Intense Competition [high — market]: Amesite operates in a highly competitive landscape, facing established EMR/EHR firms and new AI-first entrants. Convincing customers to adopt their technology-driven approach against entrenched players is a substantial hurdle.
• Navigating Healthcare Market Demands [medium — operational]: Successfully navigating customer, regulatory, and user requirements within the complex healthcare sector, particularly post-acute care, presents ongoing operational challenges. The company must demonstrate its ability to meet these demands.
• Regulatory Compliance [medium — regulatory]: Ensuring strict adherence to healthcare regulations, including HIPAA, is paramount for the NurseMagic B2B solution. Non-compliance could lead to significant penalties and reputational damage.
• Patent and Trademark Protection [low — intellectual property]: While Amesite holds fourteen U.S. patents and one pending application, the company's competitive advantage relies on the effective protection and utilization of its intellectual property against potential infringement.

Industry Context

Amesite is strategically repositioning itself within the healthcare technology sector, specifically targeting the post-acute care market with AI-powered solutions. This market is characterized by significant operational complexities, stringent regulatory requirements (like HIPAA), and a growing demand for efficiency improvements. The competitive landscape includes established Electronic Health Record (EHR) providers and emerging AI-first companies, making differentiation and market penetration challenging.

Regulatory Implications

Amesite's focus on the healthcare sector, particularly with its B2B NurseMagic platform, necessitates strict adherence to regulations such as HIPAA. Failure to comply with data privacy and security mandates could result in severe penalties and damage the company's reputation. The company must demonstrate robust compliance measures to gain trust and adoption from healthcare organizations.

What Investors Should Do

1. [object Object]
2. [object Object]
3. [object Object]
4. [object Object]

Key Dates

• 2025-XX-XX: Fiscal Year 2025 Strategic Pivot — Company shifted focus from education to AI-powered healthcare solutions, specifically post-acute care, marking a significant change in business strategy.
• 2024-12-31: Market Valuation and Stock Price — Aggregate market value of common stock held by non-affiliates was $15,375,000 with a closing price of $4.75 per share, providing a snapshot of current market valuation.
• 2025-09-29: Shares of Common Stock Outstanding — 4,572,713 shares outstanding as of this date, relevant for per-share calculations and market capitalization.

Glossary

Post-acute care market

Healthcare services provided to patients after a hospital stay, focusing on recovery and rehabilitation, such as home health and skilled nursing facilities. (This is the primary target market for Amesite's NurseMagic solutions following their strategic pivot.)

B2C (Business-to-Consumer)

A business model where products or services are sold directly to individual consumers. (Refers to Amesite's NurseMagic app designed for individual nurses and caregivers.)

B2B (Business-to-Business)

A business model where products or services are sold to other businesses. (Refers to Amesite's NurseMagic enterprise platform sold to healthcare organizations.)

HIPAA

Health Insurance Portability and Accountability Act of 1996, a U.S. law that provides data privacy and security provisions for safeguarding medical information. (Compliance with HIPAA is a key feature and requirement for Amesite's B2B healthcare solutions.)

EMR/EHR

Electronic Medical Record (EMR) and Electronic Health Record (EHR) systems are digital versions of patients' paper charts. (Established EMR/EHR firms represent significant competition for Amesite in the healthcare technology market.)

Year-Over-Year Comparison

The provided text focuses on the fiscal year 2025 and does not contain comparative data from a previous filing. However, it highlights a significant strategic pivot from an education-centric model to AI-powered healthcare solutions. This implies a fundamental shift in business operations, target markets, and potentially revenue streams compared to prior periods. The company's emphasis on the NurseMagic brand and the post-acute care market suggests a departure from its previous educational product lines.

Key Financial Figures

• $0.0001 — ich registered Common Stock, par value $0.0001 AMST The Nasdaq Stock Market LLC Secu
• $4.75 — Capital Market on December 31, 2024 of $4.75. On September 29, 2025, there were 4,5
• $1.0 billion — n Michigan, financing, on average, over $1.0 billion annually. Mr. Bernard has been involved
• $18.6 billion — te financial transactions totaling over $18.6 billion. Mr. Bernard specializes in both debt a

Filing Documents

• ea0254427-10k_amesite.htm (10-K) — 645KB
• ea0254427ex23-1_amesite.htm (EX-23.1) — 2KB
• ea0254427ex23-2_amesite.htm (EX-23.2) — 2KB
• ea0254427ex31-1_amesite.htm (EX-31.1) — 8KB
• ea0254427ex31-2_amesite.htm (EX-31.2) — 8KB
• ea0254427ex32-1_amesite.htm (EX-32.1) — 3KB
• ea0254427ex32-2_amesite.htm (EX-32.2) — 3KB
• image_001.jpg (GRAPHIC) — 18KB
• image_002.jpg (GRAPHIC) — 15KB
• image_003.jpg (GRAPHIC) — 5KB
• image_004.jpg (GRAPHIC) — 11KB
• 0001213900-25-093213.txt ( ) — 4557KB
• amst-20250630.xsd (EX-101.SCH) — 46KB
• amst-20250630_cal.xml (EX-101.CAL) — 36KB
• amst-20250630_def.xml (EX-101.DEF) — 208KB
• amst-20250630_lab.xml (EX-101.LAB) — 426KB
• amst-20250630_pre.xml (EX-101.PRE) — 231KB
• ea0254427-10k_amesite_htm.xml (XML) — 395KB

Business

Business 1 Item 1A.

Risk Factors

Risk Factors 6 Item 1B. Unresolved Staff Comments 15 Item 1C. Cybersecurity 15 Item 2.

Properties

Properties 15 Item 3.

Legal Proceedings

Legal Proceedings 15 Item 4. Mine Safety Disclosures 15 Part II 16 Item 5. Market For Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 16 Item 6. [Reserved]. 16 Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations 17 Item 7A.

Quantitative and Qualitative Disclosures

Quantitative and Qualitative Disclosures about Market Risk 20 Item 8.

Financial Statements and Supplementary

Financial Statements and Supplementary Data F-1 Item 9. Changes in and Disagreements With Accountants on Accounting and Financial Disclosure 21 Item 9A.

Controls and Procedures

Controls and Procedures 21 Item 9B. Other Information 21 Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections 21 Part III 22 Item 10. Directors, Executive Officers and Corporate Governance 22 Item 11.

Executive Compensation

Executive Compensation 22 Item 12.

Security Ownership of Certain Beneficial

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters 22 Item 13. Certain Relationships and Related Transactions, and Director Independence 22 Item 14. Principal Accountant Fees and Services 22 Part IV 23 Item 15. Exhibits and Financial Statement Schedules 23 Item 16. Form 10-K Summary 24

Signatures

Signatures 25 -i- CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS This Annual Report on Form 10-K contains "forward-looking statements," which include information relating to future events, future financial performance, financial projections, strategies, expectations, competitive environment and regulation. Words such as "may," "should," "could," "would," "predicts," "potential," "continue," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates," and similar expressions, as well as statements in future tense, identify forward-looking statements. Forward-looking statements should not be read as a guarantee of future performance or results and may not be accurate indications of when such performance or results will be achieved. Forward-looking statements are based on information we have when those statements are made or management's good faith belief as of that time with respect to future events, and are subject to a number of risks, and uncertainties and assumptions that could cause actual performance or results to differ materially from those expressed in or suggested by the forward-looking statements. These risks are more fully described in the "Risk Factors" section of this Annual Report on Form 10-K. Amesite, Inc.'s suite of assets is collectively referred to as our "Site." Our Site includes all of our products and services and all of the technology and business services that create them, in part or whole: a blend of software, hardware, content, and technology that includes everything from behind-the-scenes processes to the user interface, our website, data handling, communication, and advanced analytics. The NurseMagic website available at https://www.nursemagic.ai, and/or our mobile app available at https://app.nursemagic.ai, NurseMagic is a product owned and operated by Amesite, Inc. ("Amesite," "we," "our," or "us"). The following is a summary of risks related to our Site: our planned expansions and improvements to our

BUSINESS

ITEM 1. BUSINESS Overview Amesite is a technology company focused on building and commercializing AI-powered solutions for the healthcare sector, with particular emphasis on the post-acute care market. In fiscal 2025, we completed our pivot from an education-centric model to one firmly anchored in the demands and opportunities of healthcare—a shift driven by the scale, complexity, and attractive growth potential of this sector. We operate through two product lines under our NurseMagic brand: a B2C (direct-to-practitioner) app and a B2B (enterprise) platform. These solutions directly address operational, compliance, and efficiency challenges faced by healthcare professionals and organizations. Our B2C NurseMagic app connects directly with working nurses and caregivers, providing tools to reduce documentation time, simplify communication, and support daily workflow. Feedback and usage patterns from these users have been instrumental, allowing us to rapidly refine features and ensure our offerings are relevant to current industry demands. Building on these real-world insights, our B2B NurseMagic solution serves healthcare businesses—including home health, skilled nursing, hospice, and non-clinical segments. Enterprises adopting NurseMagic see improvements in workflow efficiency, data security, and regulatory compliance, all foundational to driving sustainable business performance. Our offerings are engineered for fast, secure deployment and measurable value in demanding business environments. We believe that we have a pathway to deliver AI solutions impactfully, quickly, and compliantly across this expansive, underserved segment. Adoption by both caregivers and enterprise partners demonstrates the relevance and commercial fit of our technology. Growth in contracted organizations and end users, alongside positive market feedback, provides further confidence in the direction we have chosen—even as we remain measured and pragmatic about future expansion. Significa